OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines
Bruno Braz Bezerra, Gustavo Peixoto Duarte da Silva, Sharton Vinícius Antunes Coelho, et al.
Antiviral Research (2022) Vol. 205, pp. 105373-105373
Open Access | Times Cited: 13
Bruno Braz Bezerra, Gustavo Peixoto Duarte da Silva, Sharton Vinícius Antunes Coelho, et al.
Antiviral Research (2022) Vol. 205, pp. 105373-105373
Open Access | Times Cited: 13
Showing 13 citing articles:
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 8
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 8
Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin
Cory Hewitt, Nicholas Wixon, Arthur Gallegos, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 79-79
Open Access
Cory Hewitt, Nicholas Wixon, Arthur Gallegos, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 79-79
Open Access
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections: A Preclinical Study
Angela Lu, Brandon Ebright, Aditya Naik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2061-2061
Open Access | Times Cited: 2
Angela Lu, Brandon Ebright, Aditya Naik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2061-2061
Open Access | Times Cited: 2
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells
Silvia Alboni, Valentina Secco, Bianca Papotti, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 647-647
Open Access | Times Cited: 4
Silvia Alboni, Valentina Secco, Bianca Papotti, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 647-647
Open Access | Times Cited: 4
β-Cyclodextrins as affordable antivirals to treat coronavirus infection
Dàlia Raϊch‐Regué, Raquel Tenorio, Isabel Fernández de Castro, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114997-114997
Open Access | Times Cited: 4
Dàlia Raϊch‐Regué, Raquel Tenorio, Isabel Fernández de Castro, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114997-114997
Open Access | Times Cited: 4
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Cyclodextrin-Derived Drug Delivery Systems in Respiratory Diseases
Vineet Kumar, Jitu Halder, Tushar Kanti Rajwar, et al.
(2023), pp. 129-145
Closed Access | Times Cited: 2
Vineet Kumar, Jitu Halder, Tushar Kanti Rajwar, et al.
(2023), pp. 129-145
Closed Access | Times Cited: 2
Cyclodextrin in Vaccines: Enhancing Efficacy and Stability
Gamze Varan
Future Pharmacology (2023) Vol. 3, Iss. 3, pp. 597-611
Open Access | Times Cited: 2
Gamze Varan
Future Pharmacology (2023) Vol. 3, Iss. 3, pp. 597-611
Open Access | Times Cited: 2
Molecular insights to the anti-COVID-19 potential of α-, β- and γ-cyclodextrins
Vipul Kumar, Hazna Noor Meidinna, Sunil C. Kaul, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-11
Closed Access | Times Cited: 1
Vipul Kumar, Hazna Noor Meidinna, Sunil C. Kaul, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-11
Closed Access | Times Cited: 1
33rd Brazilian Society for Virology (SBV) 2022 Annual Meeting
Maité F. S. Vaslin, Gustavo Peixoto Duarte da Silva, Alessandra Alevato Leal, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 943-943
Open Access
Maité F. S. Vaslin, Gustavo Peixoto Duarte da Silva, Alessandra Alevato Leal, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 943-943
Open Access
Cholesterol depletion inhibits rabies virus infection by restricting viral adsorption and fusion
Qingxiu Hou, Caiqian Wang, Jingyi Xiong, et al.
Veterinary Microbiology (2023) Vol. 289, pp. 109952-109952
Closed Access
Qingxiu Hou, Caiqian Wang, Jingyi Xiong, et al.
Veterinary Microbiology (2023) Vol. 289, pp. 109952-109952
Closed Access
β-Cyclodextrins as affordable antivirals to treat coronavirus infection
Dàlia Raϊch‐Regué, Raquel Tenorio, Isabel Fernández de Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Dàlia Raϊch‐Regué, Raquel Tenorio, Isabel Fernández de Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
